Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH)

 
CONTENT
60093
Federal Register / Vol. 84, No. 216 / Thursday, November 7, 2019 / Notices
1. Christian J. Ryan, Byron,
Minnesota; to acquire voting shares of
Olmsted Bancorporation, Inc., and
thereby indirectly acquire voting shares
of First Security Bank, both of Byron,
Minnesota.
Board of Governors of the Federal Reserve
System, November 1, 2019.
Michele Taylor Fennell,
Assistant Secretary of the Board.
[FR Doc. 2019–24241 Filed 11–6–19; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
AGENCY
: Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION
: Notice of meeting.
SUMMARY
: In accordance with the
Federal Advisory Committee Act, the
CDC, announces the following meeting
of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, limited only by
the space available. The meeting space
accommodates approximately 150
people and the audio conference line
has 150 ports for callers. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
teleconference (information below).
DATES
: The meeting will be held on
December 11, 2019 from 8:15 a.m. to
5:30 p.m., PST. A public comment
session will be held on December 11,
2019 at 5:30 p.m., PST and conclude at
6:30 p.m., PST or following the final call
for public comment, whichever comes
first.
ADDRESSES
: Hilton Oakland Airport
Hotel, One Hegenberger Road, Oakland,
California 94621; Phone: (510) 635–
5000, Fax: (510) 383–4090. The public
may join the audio conference call via
FTS Conferencing. The USA toll-free
dial-in number is 1–866–659–0537; and
the pass code is 9933701. The meeting
will also be accessible via Web
conference by Skype: meeting
CONNECTION: https://
webconf.cdc.gov/zab6/yzdq02pl?sl=1.
FOR FURTHER INFORMATION CONTACT
:
Theodore Katz, MPA, Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road, Mailstop E–20, Atlanta,
Georgia 30329–4027, Telephone (513)
533–6800, Toll Free 1 (800) CDC–INFO,
Email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION
:
BACKGROUND: The Advisory Board
was established under the
Energy Employees Occupational
Illness Compensation Program Act of
2000 to advise the President on a variety
of policy and technical functions
required to implement and effectively
manage the new compensation program.
Key functions of the Advisory Board
include providing advice on the
development of probability of causation
guidelines which have been
promulgated by the Department of
Health and Human Services (HHS) as a
final rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule,
advice on the scientific validity and
quality of dose estimation and
reconstruction efforts being performed
for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special
Exposure Cohort (SEC). In December
2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The Advisory Board’s charter was
issued on August 3, 2001, renewed at
appropriate intervals, rechartered on
February 12, 2018, and will terminate
on February 12, 2020.
PURPOSE: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
MATTERS TO BE CONSIDERED: The
agenda will include discussions on the
following: NIOSH Program Update;
Department of Labor Program Update;
Department of Energy Program Update;
SEC Petitions Update; Completed Site
Profile Reviews; Draft Report to the
Secretary, HHS on Dose Reconstruction
Reviews, Coworker Modeling
Guidelines Review; SEC Petition Review
Update for Savannah River Site (Aiken,
South Carolina, 1972–2007); Lawrence
Berkeley National Laboratory Site
Profile Review Update; and a Board
Work Session. Agenda items are subject
to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–24244 Filed 11–6–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–2013–N–0375, FDA–
2013–N–0520, FDA–2008–D–0031, FDA–
2012–N–0386, FDA–2013–N–0377, FDA–
2011–D–0147, FDA–2013–N–1588, FDA–
2013–N–0093, and FDA–2016–N–1593]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approvals
AGENCY
: Food and Drug Administration,
HHS.
ACTION
: Notice.
SUMMARY
: The Food and Drug
Administration (FDA) is publishing a
list of information collections that have
been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT
: Ila
S. Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–7726, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION
: The
following is a list of FDA information
collections recently approved by OMB
under section 3507 of the Paperwork
Reduction Act of 1995 (44 U.S.C. 3507).
The OMB control number and
expiration date of OMB approval for
VerDate Sep<11>2014 17:55 Nov 06, 2019 Jkt 250001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\07NON1.SGM 07NON1